tiprankstipranks
Trending News
More News >
Halozyme downgraded to Equal Weight from Overweight at Morgan Stanley
PremiumThe FlyHalozyme downgraded to Equal Weight from Overweight at Morgan Stanley
24d ago
Hold Rating Issued Amid Uncertainty in Drug Pricing Regulations Impacting Halozyme
Premium
Ratings
Hold Rating Issued Amid Uncertainty in Drug Pricing Regulations Impacting Halozyme
24d ago
UnitedHealth suspends outlook, Under Armour reports Q4 beat; Morning Buzz
Premium
The Fly
UnitedHealth suspends outlook, Under Armour reports Q4 beat; Morning Buzz
24d ago
Halozyme Therapeutics Reports Strong Earnings and Growth
PremiumCompany AnnouncementsHalozyme Therapeutics Reports Strong Earnings and Growth
30d ago
Halozyme’s Strong Financial Performance and Strategic Developments Justify Buy Rating with $75 Price Target
Premium
Ratings
Halozyme’s Strong Financial Performance and Strategic Developments Justify Buy Rating with $75 Price Target
1M ago
Buy Rating for Halozyme Amid Legal Battle with Merck: Potential Multi-Billion-Dollar Royalty Opportunity
Premium
Ratings
Buy Rating for Halozyme Amid Legal Battle with Merck: Potential Multi-Billion-Dollar Royalty Opportunity
1M ago
Halozyme reports Q1 non-GAAP EPS $1.11, consensus 94c
PremiumThe FlyHalozyme reports Q1 non-GAAP EPS $1.11, consensus 94c
1M ago
Halozyme raises FY25 non-GAAP EPS view to $5.30-$5.70 from $4.95-$5.35
Premium
The Fly
Halozyme raises FY25 non-GAAP EPS view to $5.30-$5.70 from $4.95-$5.35
1M ago
Halozyme Therapeutics (HALO) Q1 Earnings Cheat Sheet
Premium
Pre-Earnings
Halozyme Therapeutics (HALO) Q1 Earnings Cheat Sheet
1M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100